OrthoPediatrics Raises FY2026 Sales Guidance from $263.000M-$267.000M to $265.000M-$269.000M vs $265.240M Est

Benzinga Newsdesk www.benzinga.com Positive 94.0%

Neg 0% Neu 0% Pos 94%

OrthoPediatrics (NASDAQ:KIDS) raises FY2026 sales outlook from $263.000 million-$267.000 million to $265.000 million-$269.000 million vs $265.240 million estimate.